Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Third Harmonic Bio, Inc. Common Stock (THRD)

Pharmaceutical Preparations

https://www.thirdharmonicbio.com

Third Harmonic Bio Inc is a clinical-stage company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases.. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival.

1700 MONTGOMERY STREET, SUITE 210
SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/15/2022

Market Cap

481,565,685

Shares Outstanding

40,360,000

Weighted SO

40,362,572

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

SNSE --.--%

NXTC --.--%

NUVB --.--%

GRPH --.--%

MACK --.--%

CGEM --.--%

EWTX --.--%

RLYB --.--%

GLUE --.--%

Beta

0.0000

Last Div

0.0000

Range

5.41-16.94

Chg

-0.3200

Avg Vol

88972

Mkt Cap

481565685

Exch

NASDAQ

Country

US

Phone

617-915-6680

DCF Diff

5.1678

DCF

6.6872

Div Yield

0.0000

P/S

576.0355

EV Multiple

-9.2370

P/FV

1.8578

Div Yield %

0.0000

P/E

-26.4141

PEG

-1.4088

Payout

0.0000

Current Ratio

41.1255

Quick Ratio

41.1255

Cash Ratio

40.1969

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

2442.9535

CCC

-2442.9535

Gross Margin

0.7428

Op Margin

-29.8062

Pretax Margin

-21.5981

Net Margin

-21.5981

Eff Tax Rate

-0.0124

ROA

-0.0679

ROE

-0.0680

ROCE

-0.0960

NI/EBT

1.0000

EBT/EBIT

0.7246

EBIT/Rev

-29.8062

Debt Ratio

0.0135

D/E

0.0140

LT Debt/Cap

0.0108

Total Debt/Cap

0.0138

Int Coverage

8.5835

CF/Debt

-6.9293

Equity Multi

1.0356

Rec Turnover

0.0000

Pay Turnover

0.1494

Inv Turnover

0.0000

FA Turnover

0.2352

Asset Turnover

0.0031

OCF/Share

-0.6137

FCF/Share

-0.6138

Cash/Share

6.2958

OCF/Sales

-29.7727

FCF/OCF

1.0000

CF Coverage

-6.9293

ST Coverage

-31.0737

CapEx Coverage

-24890.0000

Div&CapEx Cov

-24890.0000

P/BV

1.8578

P/B

1.8578

P/S

576.0355

P/E

-26.4141

P/FCF

-19.3470

P/OCF

-19.1616

P/CF

-19.1616

PEG

-1.4088

P/S

576.0355

EV Multiple

-9.2370

P/FV

1.8578

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 09, 08:30 Third Harmonic Bio Announces Third Quarter 2023 Financial Results

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.12 08/06/2014 07/30/2014 08/08/2014 08/15/2014
0.12 05/06/2014 04/24/2014 05/08/2014 05/15/2014
0.12 02/05/2014 01/27/2014 02/07/2014 02/14/2014
0.10 11/06/2013 10/24/2013 11/08/2013 11/15/2013
0.10 08/06/2013 07/25/2013 08/08/2013 08/15/2013
0.05 05/06/2013 04/25/2013 05/08/2013 05/15/2013
0.05 02/06/2013 01/24/2013 02/08/2013 02/15/2013
0.05 11/06/2012 10/25/2012 11/30/-0001 11/15/2012
0.05 08/06/2012 07/26/2012 11/30/-0001 08/15/2012
0.05 05/04/2012 04/27/2012 11/30/-0001 05/15/2012
0.05 02/06/2012 01/26/2012 11/30/-0001 02/15/2012
0.05 11/04/2011 10/27/2011 11/30/-0001 11/15/2011
0.05 08/04/2011 07/29/2011 11/30/-0001 08/15/2011
0.05 05/05/2011 04/28/2011 11/30/-0001 05/16/2011
0.05 02/04/2011 01/31/2011 11/30/-0001 02/15/2011
0.20 11/04/2010 10/28/2010 11/30/-0001 11/15/2010
0.20 08/05/2010 07/29/2010 11/30/-0001 08/16/2010
0.20 05/06/2010 04/29/2010 11/30/-0001 05/14/2010
0.20 02/05/2010 01/28/2010 11/30/-0001 02/16/2010
0.20 11/05/2009 10/29/2009 11/30/-0001 11/16/2009
0.20 08/05/2009 07/23/2009 11/30/-0001 08/14/2009